ストックスクリーナーアプリを入手
0.8102
12.88%
-0.1198
アフターアワーズ：
.82
0.0098
+1.21%
Dare Bioscience Inc (DARE) 最新ニュース
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: C - GuruFocus
Dare Bioscience Prices $6.0 Million Registered Direct Offering - Minichart
Form 8K Dare Bioscience Inc For: 17 August By Investing.com - Investing.com Canada
Daré Bioscience Raises ~$6 Million in Equity Offering at $1.37 With Attached Warrants - TradingView
H.C. Wainwright reiterates Dare Bioscience stock rating at buy By Investing.com - Investing.com Canada
symbol__ Stock Quote Price and Forecast - CNN
Q2 2026 Dare Bioscience Inc Earnings Call Transcript - GuruFocus
H.C. Wainwright Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Daré Bioscience raises $6M in registered direct offering By Investing.com - Investing.com India
Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall - marketscreener.com
Daré Bioscience raises $6M in registered direct offering - Investing.com
Daré Bioscience Announces $6.0 Million Registered Direct Offering and Concurrent Private Placement - Moomoo
Dare Bioscience earnings beat by $0.11, revenue topped estimates - Investing.com Canada
Daré Bioscience (DARE) Launches New Product Amid Challenging Val - GuruFocus
Dare Bioscience (DARE) Q2 Results Highlight Challenges Amid Low Valuation on Price-to-Sales Basis - GuruFocus
Earnings call transcript: Daré Bioscience Q2 2026 loss narrows as stock jumps after hours - Investing.com
Dare Bioscience Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Dare Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Dare Bioscience Q2 net loss narrows as revenue rises, R&D expenses decline - TradingView
Dare Bioscience Q2 Results: Net loss narrows to $3.0M, cash falls - scanx.trade
Dare Bioscience, Inc. 2026: Revenue $187.55K, EPS ($0.2) — 10-Q Summary - TradingView
Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances - The Manila Times
Daré Bioscience launches Flora Sync, its first directly commercialized product - Stock Titan
Dare Bioscience reports Q2 2026: $0.19M revenue, $2.98M net loss, cash $12.6M - TradingView
Dare Bioscience Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Transcript : Daré Bioscience, Inc.Special Call - marketscreener.com
Dare Bioscience Inc (DARE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dare Bioscience (DARE.US) will release its earnings report after market close on August 13. - Moomoo
Dare Bioscience (DARE) Eases 0.75% to $1.33: Stock Hovers Between Key Support and ResistanceHedge Fund Exposure - dars.gov.et
Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026 - The Manila Times
Daré Bioscience to Host Second Quarter 2026 Financial - globenewswire.com
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
Dare Bioscience Expands Access Options for DARE to PLAY and Specialized Menopause Care through Strategic Collaboration with MyMenopauseRx - marketscreener.com
Dare Bioscience Inc (DARE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Dare Slides on MyMenopauseRx Hookup - Baystreet.ca
Daré Bioscience partners with menopause telehealth platform By Investing.com - Investing.com Nigeria
Daré Bioscience partners with menopause telehealth platform - Investing.com
Daré Bioscience Expands Access Options for DARE to PLAY™ - globenewswire.com
Women Exploring DARE to PLAY Can Now Reach Menopause Specialists - Stock Titan
DARE|Dare Bioscience Inc|Price:1.330|Chg%:+0.050 - TradingKey
Dare Bioscience Inc (DARE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Dare Bioscience, Inc. Revenue Breakdown – NASDAQ:DARE - TradingView
Dare Bioscience Inc (DARE) Income Statement - TradingKey
Dare Bioscience Inc (DARE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Dare Bioscience Inc (DARE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Dare Bioscience Inc (DARE) Cash Flow - TradingKey
Dare Bioscience Inc (DARE) Institutional Confidence - TradingKey
Dare Bioscience Market Sentiment - Benzinga España
DARE|Dare Bioscience Inc|Price:1.280|Chg%:+0.020 - TradingKey
Daré Bioscience Releases New Investor Corporate Presentation - TipRanks
Dare Bioscience Inc. (DARE) Holds Steady at $1.26: Consolidation Phase May Signal Next MoveDark Pool Sentiment - dars.gov.et
Daré Bioscience, Inc. (NASDAQ:DARE): Are Analysts Optimistic? - simplywall.st
Daré Bioscience launches virtual bus tour webin... - Pluang
Daré Bioscience Launches “Across the U.S.” Virtual Bus Tour Webinar Series for Investors - Quiver Quantitative
Daré Bioscience Launches Nationwide Virtual Bus Tour - GlobeNewswire
Daré Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities - The Manila Times
Dare Bioscience (DARE) Edges Higher: Testing Key Resistance Near $2.06Continuation Pattern Picks - dars.gov.et
Daré Bioscience Files 8-K Notice of Delisting or Failure to Satisfy Nasdaq Listing Requirements – July 2026 - Minichart
Daré Bioscience Faces Nasdaq Listing Compliance Challenges - TipRanks
Dare Bioscience Received Notice of Delisting - TradingView
Daré Bioscience Advances DARE-HPV Trial, Raising New Questions for HPV Treatment Investors - TipRanks
Dare Bioscience (DARE) Shares Decline 3.38% as Stock Holds Above Key Support at $1.9BPI Bear Correction - dars.gov.et
Daré Bioscience at Virtual Investor Closing Bell: shift to sales By Investing.com - Investing.com Canada
DARE: Commercial launches and clinical milestones in women's health drive growth and value through 2027 - TradingView
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025 - 富途牛牛
Daré Bioscience Updates Investors With New Presentation - TipRanks
1.80%
1.77%
大文字化:
|
ボリューム (24 時間):